Steelhead Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50,000
Closed -$106K 41
2022
Q1
$106K Buy
+50,000
New +$122K 0.01% 41
2021
Q4
Sell
-11,615
Closed -$58K 40
2021
Q3
$58K Hold
11,615
﹤0.01% 40
2021
Q2
$76K Sell
11,615
-22,961
-66% -$160K 0.01% 43
2021
Q1
$238K Buy
+34,576
New +$292K 0.02% 39

Other funds holding PGEN

Steelhead Partners's PGEN Position: Q2 2022 in Review

Steelhead Partners sold out of Precigen (PGEN) in Q2 2022, closing a stake of 50,000 shares — an estimated $106K sold.

Steelhead Partners first reported a position in PGEN in Q1 2021 and held it in 4 quarters. The position peaked at $238K in Q1 2021. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2022.

  • Steelhead Partners reported no remaining Precigen position as of Q2 2022 after selling out during the quarter.
  • Steelhead Partners sold 50,000 Precigen shares in Q2 2022, an estimated $106K.
  • Steelhead Partners first reported a position in Precigen in Q1 2021 and held it in 4 quarters.
  • Steelhead Partners's Precigen position peaked at $238K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2022.

Based on Steelhead Partners's 13F filing for Q2 2022, filed 16 Aug 2022.